National Bank of Canada
PDSB icon

National Bank of Canada’s PDS Biotechnology PDSB Stock Holding History

National Bank of Canada’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$1 – 3131
2025
Q2 		$1 Hold
1
– – ﹤0.01% 2971
2025
Q1 		$1 Hold
1
– – ﹤0.01% 2826
2024
Q4 		$2 Hold
1
– – ﹤0.01% 2907
2024
Q3 		$4 Buy
+1
New +$3 ﹤0.01% 2718
2022
Q3 		– Sell
-2,200
Closed -$8K – 2835
2022
Q2 		$8K Buy
2,200
+1,300
+144% +$6.18K ﹤0.01% 2326
2022
Q1 		$6K Buy
900
+300
+50% +$1.86K ﹤0.01% 2516
2021
Q4 		$5K Buy
+600
New +$6.46K ﹤0.01% 2543

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

National Bank of Canada's PDSB Position: Q3 2025 in Review

National Bank of Canada sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 1 share — an estimated $1 sold.

National Bank of Canada first reported a position in PDSB in Q4 2021 and held it in 7 quarters. The position peaked at $8K in Q2 2022. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • National Bank of Canada reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 1 PDS Biotechnology share in Q3 2025, an estimated $1.
  • National Bank of Canada first reported a position in PDS Biotechnology in Q4 2021 and held it in 7 quarters.
  • National Bank of Canada's PDS Biotechnology position peaked at $8K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.